174 related articles for article (PubMed ID: 38501836)
21. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
Al-Baqsami ZF; Ahmad S; Khan Z
Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
[TBL] [Abstract][Full Text] [Related]
22.
Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
24. Antifungal susceptibility profile of invasive
Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
[No Abstract] [Full Text] [Related]
25. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
Cretella D; Barber KE; King ST; Stover KR
J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
[TBL] [Abstract][Full Text] [Related]
26. Comparative evaluation of Sensititre YeastOne and VITEK 2 against the Clinical and Laboratory Standards Institute M27-E4 reference broth microdilution method for the antifungal susceptibility testing of Cryptococcus neoformans and Cryptococcus gattii.
Zhang M; Zhou Z; Wang D; Zhou A; Song G; Chen X; Guo J; Wu W
Med Mycol; 2022 Mar; 60(3):. PubMed ID: 35099022
[TBL] [Abstract][Full Text] [Related]
27. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
28. [Evaluation of the VITEK 2 system (AST-YSO1 cards) for antifungal susceptibility testing against different Candida species].
Ochiuzzi ME; Arechavala A; Guelfand L; Maldonado I; Soloaga R;
Rev Argent Microbiol; 2014; 46(2):111-8. PubMed ID: 25011594
[TBL] [Abstract][Full Text] [Related]
29. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
[TBL] [Abstract][Full Text] [Related]
30. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.
Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Moet GJ; Jones RN
J Clin Microbiol; 2010 May; 48(5):1592-9. PubMed ID: 20335424
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common
Lim HJ; Shin JH; Kim MN; Yong D; Byun SA; Choi MJ; Lee SY; Won EJ; Kee SJ; Kim SH; Shin MG
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32900684
[TBL] [Abstract][Full Text] [Related]
32. Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
Bourgeois N; Dehandschoewercker L; Bertout S; Bousquet PJ; Rispail P; Lachaud L
J Clin Microbiol; 2010 Jan; 48(1):154-61. PubMed ID: 19889902
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of anidulafungin, caspofungin, fluconazole and amphotericin B against biofilms and planktonic forms of Candida species isolated from blood culture in patients with hematological malignancies.
Malchikova A; Klyasova G
J Mycol Med; 2021 Sep; 31(3):101162. PubMed ID: 34147758
[TBL] [Abstract][Full Text] [Related]
34. Activities of nine antifungal agents against Candida auris biofilms.
Chatzimoschou A; Giampani A; Meis JF; Roilides E
Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
[TBL] [Abstract][Full Text] [Related]
35. Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance.
Kordalewska M; Cancino-Prado G; Nobrega de Almeida Júnior J; Brasil Brandão I; Tigulini de Souza Peral R; Colombo AL; Perlin DS
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0042323. PubMed ID: 37222585
[TBL] [Abstract][Full Text] [Related]
36. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
J Clin Microbiol; 2007 Nov; 45(11):3522-8. PubMed ID: 17913927
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary-care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibility to echinocandins.
Asadzadeh M; Mokaddas E; Ahmad S; Abdullah AA; de Groot T; Meis JF; Shetty SA
Mycoses; 2022 Mar; 65(3):331-343. PubMed ID: 34953089
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
[TBL] [Abstract][Full Text] [Related]
39. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
[TBL] [Abstract][Full Text] [Related]
40. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
